The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository
Start Date
10/28/2020
Completion Date
11/30/2031
Summary
This study will investigate the association between clonal hematopoiesis and other conditions. Clonal hematopoiesis (CH) refers to the mutations in a person's stem cells which commonly affect people as they get older. These mutations have notably been linked to increased risk of certain cancers as well as increased risk of heart disease.
Detailed Description
Objectives: * To develop the CHIVE Registry with CH patients or patients with elevated risk for CH in order to better characterize associated clinical outcomes and co-morbidities in these populations * To improve understanding of cardiovascular phenotypes and risk of patients with known Clonal Hematopoiesis of indeterminate potential (CHIP) or Clonal Cytopenias of undetermined significance (CCUS) * To investigate prognostic significance of CH mutations for the development hematologic malignancies * To generate a CHIVE Biorepository to acquire patient samples to study the natural history of CH, and to make available to CH investigators.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Blood collection
Saliva collection
Bone marrow collection
Conditions
Locations
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee 37203
United States